
Macerich Co
NYSE:MAC

Macerich Co?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
13.24
22.11
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Macerich Co hold over its rivals?
What risks and challenges
does Macerich Co face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Macerich Co.
Provide an overview of the primary business activities
of Macerich Co.
What unique competitive advantages
does Macerich Co hold over its rivals?
What risks and challenges
does Macerich Co face in the near future?
Has there been any significant insider trading activity
in Macerich Co recently?
Summarize the latest earnings call
of Macerich Co.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Macerich Co.
Provide P/S
for Macerich Co.
Provide P/E
for Macerich Co.
Provide P/OCF
for Macerich Co.
Provide P/FCFE
for Macerich Co.
Provide P/B
for Macerich Co.
Provide EV/S
for Macerich Co.
Provide EV/GP
for Macerich Co.
Provide EV/EBITDA
for Macerich Co.
Provide EV/EBIT
for Macerich Co.
Provide EV/OCF
for Macerich Co.
Provide EV/FCFF
for Macerich Co.
Provide EV/IC
for Macerich Co.
Show me price targets
for Macerich Co made by professional analysts.
What are the Revenue projections
for Macerich Co?
How accurate were the past Revenue estimates
for Macerich Co?
What are the Net Income projections
for Macerich Co?
How accurate were the past Net Income estimates
for Macerich Co?
What are the EPS projections
for Macerich Co?
How accurate were the past EPS estimates
for Macerich Co?
What are the EBIT projections
for Macerich Co?
How accurate were the past EBIT estimates
for Macerich Co?
Compare the revenue forecasts
for Macerich Co with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Macerich Co and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Macerich Co against its competitors.
Analyze the profit margins
(gross, operating, and net) of Macerich Co compared to its peers.
Compare the P/E ratios
of Macerich Co against its peers.
Discuss the investment returns and shareholder value creation
comparing Macerich Co with its peers.
Analyze the financial leverage
of Macerich Co compared to its main competitors.
Show all profitability ratios
for Macerich Co.
Provide ROE
for Macerich Co.
Provide ROA
for Macerich Co.
Provide ROIC
for Macerich Co.
Provide ROCE
for Macerich Co.
Provide Gross Margin
for Macerich Co.
Provide Operating Margin
for Macerich Co.
Provide Net Margin
for Macerich Co.
Provide FCF Margin
for Macerich Co.
Show all solvency ratios
for Macerich Co.
Provide D/E Ratio
for Macerich Co.
Provide D/A Ratio
for Macerich Co.
Provide Interest Coverage Ratio
for Macerich Co.
Provide Altman Z-Score Ratio
for Macerich Co.
Provide Quick Ratio
for Macerich Co.
Provide Current Ratio
for Macerich Co.
Provide Cash Ratio
for Macerich Co.
What is the historical Revenue growth
over the last 5 years for Macerich Co?
What is the historical Net Income growth
over the last 5 years for Macerich Co?
What is the current Free Cash Flow
of Macerich Co?
Discuss the annual earnings per share (EPS)
trend over the past five years for Macerich Co.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Macerich Co
NYSE:MAC
|
4.5B USD | 18 | |
US |
![]() |
Simon Property Group Inc
NYSE:SPG
|
56.2B USD | 17.9 |
|
US |
![]() |
Realty Income Corp
NYSE:O
|
53B USD | 16.7 |
|
SG |
![]() |
CapitaLand Integrated Commercial Trust
SGX:C38U
|
16.2B | 0 |
|
HK |
![]() |
Link Real Estate Investment Trust
HKEX:823
|
113.9B HKD | 16.4 |
|
US |
![]() |
Kimco Realty Corp
NYSE:KIM
|
14.6B USD | 17.2 |
|
AU |
![]() |
Scentre Group
ASX:SCG
|
20B AUD | 19.8 |
|
US |
![]() |
Regency Centers Corp
NASDAQ:REG
|
13B USD | 18.7 |
|
FR |
![]() |
Klepierre SA
PAR:LI
|
9.9B EUR | 17.3 |
|
FR |
![]() |
Unibail-Rodamco-Westfield SE
AEX:URW
|
7.2B EUR | 17.4 |
|
US |
![]() |
Brixmor Property Group Inc
NYSE:BRX
|
8.1B USD | 14.9 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Macerich Co
NYSE:MAC
|
Average EV/EBITDA:
17.4
18
|
17%
|
1.1 | |
US |
![]() |
Simon Property Group Inc
NYSE:SPG
|
17.9
|
3%
|
6 |
|
US |
![]() |
Realty Income Corp
NYSE:O
|
16.7
|
7%
|
2.4 |
|
SG |
![]() |
CapitaLand Integrated Commercial Trust
SGX:C38U
|
Not Available |
4%
|
N/A |
|
HK |
![]() |
Link Real Estate Investment Trust
HKEX:823
|
16.4
|
1%
|
16.4 |
|
US |
![]() |
Kimco Realty Corp
NYSE:KIM
|
17.2
|
6%
|
2.9 |
|
AU |
![]() |
Scentre Group
ASX:SCG
|
19.8
|
9%
|
2.2 |
|
US |
![]() |
Regency Centers Corp
NASDAQ:REG
|
18.7
|
7%
|
2.7 |
|
FR |
![]() |
Klepierre SA
PAR:LI
|
17.3
|
5%
|
3.5 |
|
FR |
![]() |
Unibail-Rodamco-Westfield SE
AEX:URW
|
17.4
|
N/A | N/A |
|
US |
![]() |
Brixmor Property Group Inc
NYSE:BRX
|
14.9
|
6%
|
2.5 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.